At the request of the U.S. Food and Drug Administration (FDA), Endo Pharmaceuticals has removed from the market its long-acting opioid pain medication,Opana ER(oxymorphone hydrochloride extended release), which some patients with arthritis take tomanage chronic pain.

Continue readingAt FDA Urging, Drug Maker Pulls Opana ER Off Market→